Results indicated that FOXD2-AS1, NRAV, MED8-AS1, WARS2-AS1 and MKLN1-AS exhibited higher expressions in HCC patients (Figures 9F–J). This evidence concerns the gene NRAV and hepatocellular carcinoma.